Ownership
Private
Therapeutic Areas
OtherRheumatology
Stage
Commercial
Modalities
Bioengineered tissueBioengineered tissueBioengineered tissue

CTM Biomedical General Information

Company provides human placental connective tissue allografts for surgical use to support tissue repair and constructive remodeling

Contact Information

Website
Primary Industry
[ "Other", "Biotech", "Medical Devices" ]
Corporate Office
Miami, Florida
United States

Drug Pipeline

CTM placental connective tissue allograft
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to CTM Biomedical's pipeline data

Book a demo

Key Partnerships

Pivot MedTech, TAG Medical

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

CTM Biomedical Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view CTM Biomedical's complete valuation and funding history, request access »